Literature DB >> 18983993

Substrate specificity of human and yeast aldehyde dehydrogenases.

Ming-Fang Wang1, Chih-Li Han, Shih-Jiun Yin.   

Abstract

Human aldehyde dehydrogenase (ALDH) family may contribute to metabolism of hydrocarbons, biogenic amines, retinoids, steroids, and lipid peroxidation. We previously reported kinetic properties of human cytosolic ALDH1 and mitochondrial ALDH2 towards oxidation of the straight-chain and branched-chain aliphatic aldehydes with various chain lengths [S.J. Yin, M.F. Wang, C.L. Han, S.L. Wang, Substrate binding pocket structure of human aldehyde dehydrogenases: a substrate specificity approach, Adv. Exp. Med. Biol. 372 (1995) 9-16]. We present here substrate specificities for aromatic and heterocyclic aldehydes with purified human liver ALDH1 and ALDH2, and also with yeast mitochondrial ALDH2 for comparison. Kinetic assay for human ALDHs was performed in 50mM HEPES, pH 7.5 and 25 degrees C, containing 0.5mM NAD(+), 1.7% (v/v) acetonitrile (as a solvent carrier for aldehydes) and varied concentrations of substrate, and for yeast ALDH2 the assay was determined in the same reaction mixture except containing 3mM NAD(+) and addition of 200 mM KCl. With respect to phenylacetaldehyde, 2-phenylpropionaldehyde, benzaldehyde, p-nitrobenzaldehyde, cinnamaldehyde, 2-furaldehyde and indole-3-acetaldehyde, human liver ALDH1 exhibited K(M) ranging from 0.25 to 4.8 microM, V(max) of 0.34-2.4U/mg, and catalytic efficiency, V(max)/K(M), 0.070-3.9U/(mg microM); human ALDH2 exhibited K(M) ranging from less than 0.15-0.74 microM, V(max) of 0.039-0.51 U/mg, and V(max)/K(M), 0.15-1.0U/(mg microM). Human ALDH1 and ALDH2 exhibited substate inhibition constants (K(i)) for phenylacetaldehyde, 95 and 430 microM, respectively. Yeast ALDH2 exhibited K(M) for straight-chain aliphatic aldehydes (C1-C10), 2.3-210 microM, and substrate inhibition constants (C2-C10), 79-2900 microM, with a trend of being smaller K(M) and K(i) for longer chain lengths; and K(M) for cinnamaldehyde, benzaldehyde, and 2-furaldehyde, 5.0, 79, and 1000 microM, respectively. Therefore human ALDH1/ALDH2 and yeast ALDH2 can contribute to detoxification or metabolism of various exogenous/endogenous aliphatic and aromatic aldehydes. The systematic changes in kinetic parameters for oxidation of structurally related aldehydes may reflect subtle functional topographic distinctions of substrate pocket for human and yeast ALDHs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983993     DOI: 10.1016/j.cbi.2008.10.002

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  21 in total

1.  The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.

Authors:  Jan S Moreb; Deniz Ucar; Shuhong Han; John K Amory; Alex S Goldstein; Blanca Ostmark; Lung-Ji Chang
Journal:  Chem Biol Interact       Date:  2011-11-03       Impact factor: 5.192

2.  Differential metabolism of organic nitrates by aldehyde dehydrogenase 1a1 and 2: substrate selectivity, enzyme inactivation, and active cysteine sites.

Authors:  Pei-Suen Tsou; Nathaniel A Page; Sean G Lee; Sun Mi Fung; Wing Ming Keung; Ho-Leung Fung
Journal:  AAPS J       Date:  2011-08-05       Impact factor: 4.009

3.  Structural and kinetic characterization of recombinant 2-hydroxymuconate semialdehyde dehydrogenase from Pseudomonas putida G7.

Authors:  Simara Semíramis de Araújo; Cíntia Mara Leal Neves; Samuel Leite Guimarães; Christian P Whitman; William H Johnson; Ricardo Aparicio; Ronaldo Alves Pinto Nagem
Journal:  Arch Biochem Biophys       Date:  2015-05-29       Impact factor: 4.013

4.  Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.

Authors:  Cynthia A Morgan; Thomas D Hurley
Journal:  J Med Chem       Date:  2015-02-10       Impact factor: 7.446

Review 5.  Advances in Activity-Based Sensing Probes for Isoform-Selective Imaging of Enzymatic Activity.

Authors:  Sarah H Gardner; Christopher J Reinhardt; Jefferson Chan
Journal:  Angew Chem Int Ed Engl       Date:  2020-09-11       Impact factor: 15.336

6.  Structure and mechanism of benzaldehyde dehydrogenase from Pseudomonas putida ATCC 12633, a member of the Class 3 aldehyde dehydrogenase superfamily.

Authors:  Megan P D Zahniser; Shreenath Prasad; Malea M Kneen; Cheryl A Kreinbring; Gregory A Petsko; Dagmar Ringe; Michael J McLeish
Journal:  Protein Eng Des Sel       Date:  2017-03-01       Impact factor: 1.650

Review 7.  Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.

Authors:  Vindhya Koppaka; David C Thompson; Ying Chen; Manuel Ellermann; Kyriacos C Nicolaou; Risto O Juvonen; Dennis Petersen; Richard A Deitrich; Thomas D Hurley; Vasilis Vasiliou
Journal:  Pharmacol Rev       Date:  2012-04-27       Impact factor: 25.468

8.  Conserved catalytic residues of the ALDH1L1 aldehyde dehydrogenase domain control binding and discharging of the coenzyme.

Authors:  Yaroslav Tsybovsky; Sergey A Krupenko
Journal:  J Biol Chem       Date:  2011-05-03       Impact factor: 5.157

9.  Simultaneous involvement of a tungsten-containing aldehyde:ferredoxin oxidoreductase and a phenylacetaldehyde dehydrogenase in anaerobic phenylalanine metabolism.

Authors:  Carlotta Debnar-Daumler; Andreas Seubert; Georg Schmitt; Johann Heider
Journal:  J Bacteriol       Date:  2013-11-08       Impact factor: 3.490

10.  Characterization of the East Asian variant of aldehyde dehydrogenase-2: bioactivation of nitroglycerin and effects of Alda-1.

Authors:  Matteo Beretta; Antonius C F Gorren; M Verena Wenzl; Robert Weis; Michael Russwurm; Doris Koesling; Kurt Schmidt; Bernd Mayer
Journal:  J Biol Chem       Date:  2009-11-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.